Cadexomer iodine: An effective palliative dressing in chronic critical limb ischemia

Wounds

Volumn 21, Issue 1, 2009, Pages 15-28

  Williams, Robert L ^a,b  

^a Southeast Texas Center for Wound Care and Hyperbaric Medicine   (United States)

^b Southeast Texas Center for Wound Care and Hyperbaric Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 59149107084     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report. J Am Coll Cardiol. 2006;47(6):1239-1312.
2. Hobson RW 2nd, Lynch TG, Jamil Z, et al. Results of revascularization and amputation in severe lower extremity ischemia: a five-year clinical experience. J Vasc Surg. 1985;2(1):174-185.
3. Schina MJ Jr, Atnip RG, Healy DA, Thiele BL. Relative risks of limb revascularization and amputation in the modern era. Caridovasc Surg. 1994;2(6):754-759.
4. Dawson I, Keller BP, Brand R, Pesch-Batenburg J, Hajo van Bockel J. Late outcomes of limb loss after failed infrainguinal bypass. J Vasc Surg. 1995;21(4):613-622.
5. Møller BN, Sølund K, Hansen SL. Wound infection after lower extremity amputation because of ischemia. Arch Orthop Trauma Surg. 1985;104(4):262-264.
6. Cutson TM, Bongiorni DR. Rehabilitation of the older lower limb amputee: a brief review. J Am Geriatr Soc. 1996;44(11):1388-1393.
7. Grolman RE, Wilkerson DK, Taylor J, Allinson P, Zatina MA. Transcutaneous oxygen measurements predict a beneficial response to hyperbaric oxygen therapy in patients with nonhealing wounds and critical limb ischemia. Am Surg. 2001;67(11):1072-1079.
8. Hanna GP, Fujise K, Kjellgren O, et al. Infrapopliteal transcatheter interventions for limb salvage in diabetic patients: importance of aggressive interventional approach and role of transcutaneous oximetry. J Am Coll Cardiol. 1997;30(3):664-669.
9. Gustavson B. Cadexomer Iodine: Introduction. In: Cadexomer Iodine. Fox JA, Fisher H, eds. Stuttgart: Schattauer Verlag; 1983:35-41.
10. Bengtsson B. Iodosorb unit-dose paste. Expert report on the clinical documentation. Pedell Research AB, Lund; July 1996.
11. Schmidt RJ, Kirby AJ, Chung LY. Cadexomer iodine formulations may modulate the redox environment of wounds. In: Iodine and Wound Physiology. Cambridge, UK: Information Transfer Ltd; 1995;6:1-6.
12. Gottardi W. The influence of the chemical behaviour of iodine on the germicidal action of disinfectant solutions containing iodine. J Hosp Infect. 1985;6 (suppl A):1-11.
13. Lineaweaver W, Howard R, Soucy D, et al. Topical antimicrobial toxicity. Arch Surg. 1985;120(3):267-270.
14. Greenberg L, Ingalls JW. Bactericide/leukocide ratio: a technique for the evaluation of disinfectants. J Am Pharm Assoc Am Pharm Assoc (Baltim). 1958;47(7):531-533.
15. Cooper ML, Laxer JA, Hansbrough JF. The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma. 1991;31(6):775-784.
16. Rodeheaver G. Controversies in topical wound management. WOUNDS. 1989;1(1):19-27.
17. Rodeheaver G, Bellamy W, Kody M, et al. Bactericidal activity and toxicity of iodine-containing solutions in wounds. Arch Surg. 1982;117(2):181-186.
18. Zhou LH, Nahm WK, Badiavas E, Yufit T, Falanga V. Slow release iodine preparation and wound healing: in-vitro effects consistent with lack of in-vivo toxicity in human chronic wounds. Br J Dermatol. 2002;146(3):365-374.
19. Falanga V. Iodine-containing pharmaceuticals: a reappraisal. Proceedings of the 6th European Conference on Advances in Wound Management. London; Macmillan Magazines Ltd: 1997.
20. Gilchrist B. Should iodine be reconsidered in wound management? European Tissue Repair Society. J Wound Care. 1997;6(3):148-150.
21. Stephen RL, Kablitz C, Kitabara M, Nelson JA, Duffy DP, Kolff WJ. Peritoneal dialysis: peritonitis: saline iodine flush. Dial Transplant. 1979;8:584-655.
22. Zamora JL. Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg. 1986;151(3):400-406.
23. Wolff J, Chaikoff IL, Goldberg RC, et al. The temporary nature of the inhibitory action of excess iodine on organic iodine synthesis in the normal thyroid. Endocrinology. 1949;45(5):504-513.
24. Vijanto J. Disinfection of surgical wounds without inhibition of normal wound healing. Arch Surg. 1980;115(3):253-256.
25. Ingbar S. Normal and abnormal responses of the thyroid to excess iodine. In: Degenes G, ed. Proceedings of the International Symposium on Povidone. Lexington, KY: University of Kentucky. 1983:317-325.
26. Harcup JW, Saul PA. A study of the effect of cadexomer iodine in the treatment of venous leg ulcers. Br J Clin Pract. 1986;40(9):360-364.
27. Ormiston MC, Seymour MT, Venn GE, Cohen RI, Fox JA. Controlled trial of Iodosorb in chronic venous ulcers. Br Med J. 1985;291(6491):308-310.
28. Holloway GA Jr, Johansen KH, Barnes RW, Pierce GE. Multicenter trial of cadexomer iodine to treat venous stasis ulcer. West J Med. 1989;151(1):35-38.
29. Hillström L. Iodosorb compared to standard treatment in chronic venous leg ulcers - a multicenter study. Acta Chir Scand Suppl. 1988;544:53-56.
30. Skog E, Arnesjö B, Troëng T, et al. A randomized trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcers. Br J Dermatol. 1983;109(1):77-83.
31. Hansson C. The effects of cadexomer iodine paste in the treatment of venous leg ulcers compared with hydrocolloid dressing and paraffin gauze dressing. Cadexomer Iodine Study Group. Int J Dermatol. 1998;37(5):390-396.
32. Laudanska H, Gustavson B. In-patient treatment of chronic varicose venous ulcers. A randomized trial of cadexomer iodine versus standard dressings. J Int Med Res. 1988;16(6):428-435.
33. Lindsay G, Latta D, Lyons KGB, Livingstone ED, Thomson W. A study in general practice of the efficacy of cadexomer iodine in venous leg ulcers treated on alternate days. Acta Therapeutica. 1986;12(2):141-148.
34. Sundberg J, Meller R. A retrospective review of the use of cadexomer iodine in the treatment of chronic wounds. WOUNDS. 1997;9(3):68-86.
35. Drosou A, Falabella A, Kirsner RS. Antiseptics on wounds: an area of controversy. WOUNDS. 2003;15(5):149-166.
36. LeVeen HH, LeVeen RF, LeVeen EG. The mythology of povidone-iodine and the development of self-sterilizing plastics. Surg Gynecol Obstet. 1993;176(2):183-190.
37. Krysander L, von Scheele B. Uptake of iodine during Iodosorb treatment of burn wounds - a case report performed of five patients with burns. Perstorp Pharma Internal Report. 1994;R-BC-92-005.
38. Greener B, Hughes A, Bannister N. Absorption of chronic wound fluid by a unique cadexomer polysaccharide lowers the pH of the fluid and may indirectly inhibit the activity of proteolytic enzymes. Poster presentation: Smith & Nephew Research Centre, York Science Park, York, UK.
39. Smith D. Evaluation of model-matrix damaging potential of fresh chronic wound fluids and matrix-protecting ability of Promogran and Cadesorb. Smith & Nephew Wound Management GBU. Data on file. Report: 0410021. November 2004.
40. Dissemond J, Witthoff M, Grabbe S. Investigations on pH-values in milieus of chronic wounds during modern wound therapy. Poster presentation: World Union of Wound Healing Societies Meeting, Paris, France, July, 1994.
41. Greener B, Hughes AA, Bannister NP, Douglass J. Proteases and pH on chronic wounds. J Wound Care. 2005;14(2):59-61.
42. Mertz PM, Davis SC, Brewer LD, Franzen L. Can antimicrobials be effective without impairing wound healing? The evaluation of a cadexomer iodine ointment. WOUNDS. 1994;6(6):184-193.
43. Clark RA, Klebanoff SJ. Neutrophil-mediated tumour cell cytotoxicity: role of peroxidase system. J Exp Med. 1975;141(6):1442-1447.
44. Nathan CF, Brukner LH, Silverstein SC, Cohn ZA. Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med. 1979;149(1):84-99.
45. Moore K, Thomas A, Harding KG. The effect of Iodosorb on cytokine production by human macrophages. In: Iodine and Wound Physiology. Cambridge, UK: Information Transfer Ltd; 1995;5:1-5.
46. Moore K, Thomas A, Harding KG. Iodine released from the wound dressing Iodosorb modulates the secretion of cytokines by human macrophages responding to bacterial lipopolysaccharide. Int J Biochem Cell Biol. 1997;29(1):163-171.
47. Middelkoop E. Effects of Iodosorb on healing of full thickness wounds on pigs. In: Iodine and Wound Physiology. Cambridge, UK: Information Transfer Ltd. 1995;4:1-4.